We count visits as totals without cookies, and never follow you from one day to the next. If you accept, we also use cookies to see how people use this site, so we can improve it. Privacy policy
LHHEALTH-ASSF NAV, returns and fees — LH HEALTH INNOVATION FUND | Robowealth
Shows where this fund stands in its group. Not investment advice · Data as of 16 Nov 2026
NAV per unit
NAV (THB/unit) · 16 Nov 20266.5746YTD+0.8089 (+14.03%)
Risk
7
MDD
−9.3%
Dividend
None
AUM
0.50M
0.00%
NAV change over the selected periodN/A
Invests across funds within the same AMCSector fundSSF · Tax-deductibleCurrency hedged 86.61%
What it invests in
Fact sheet data as of 30 Oct 2026
LHHEALTH-ASSF invests through the master fund AB International Health Care Portfolio 96.78%
This fund
LHHEALTH-ASSF
Invests in units of another fund
→
The fund that actually invests
AB International Health Care Portfolio
I USD · Luxembourg
This fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
The fund spreads its money across many companies
Top 10 companies combined 54.08% of fund value
Other stocks and cash
The fund's allocation: Johnson & Johnson 9.43%, Eli Lilly and Co 9.14%, Merck & 6.22%, Unitedhealth Group 6.16%, Roche 5.15%, Novartis 4.20%, AstraZeneca 3.72%, Vertex Pharmaceuticals 3.66%, Gilead Sciences 3.61%, Bristol-Myers Squibb Co 2.80%, and other stocks and cash 45.92%
Past performance is not a guarantee of future results
Go deeper
Yearly returns
Up in 1 of 2 years · best 2025 +5.14% · worst 2024 −6.00%
Monthly returns
Positive months: 24 of 37 (65%) · Best Oct 2026 +9.34% · Worst Dec 2024 −7.31%
Tap a year to see its months · * part year
Year
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2026
+0.0
+2.1
−6.5
−0.5
+1.4
+5.0
+1.0
+3.5
−2.1
+9.3
+0.7
·
2025
+4.6
+1.0
−2.4
−2.5
−4.6
+0.7
−4.3
+3.2
+1.6
+3.1
+6.6
−1.4
2024
+2.6
+2.9
+2.1
−5.4
+3.1
+2.3
+0.3
+3.9
−4.8
−4.8
−0.1
−7.3
2023
·
·
·
·
·
·
·
·
·
·
+0.6
+3.9
Average
+2.4
+2.0
−2.3
−2.8
−0.0
+2.7
−1.0
+3.5
−1.8
+2.5
+2.0
−1.6
Holding returns: worst · median · best
Every start date since 20 Nov 2023 · 3 and 6 months are total % · 1 year and over is % per year
Worst to best (green = gain, red = loss)Half of all outcomes fall in this rangeMedian
Risk
Drawdown from peak
Largest drawdown in the selected period −24.18%Previous peak 2 Sep 2024 (NAV 6.5475) → Trough 7 Aug 2025 (NAV 4.9642) · Back to the previous peak on 4 Nov 2026, after 1 year 2 months
Currently −1.35% from the peak NAV of 6.6645 (4 Nov 2026)
Change between the 2 points
Below the previous peakLargest drawdown period (previous peak → recovery)Drawdown = NAV ÷ highest prior NAV in the selected period − 1Drag across the chart to pick 2 points (on a phone, hold with 2 fingers)
Go deeper
Return vs SD
Over 1 year, LHHEALTH-ASSF returned 0.93 per unit of SD, ranking 6 of 12 funds · The highest is BCARESSF (1.28)
Costs
Minimum first purchase0 THB
Front-end feeWaived
Buy cut-off time14:00
Sell cut-off time14:00
Redemption proceedsT+4
TER (actual)2.1648% / yr
Go deeper
Order cut-off times
Buy14:00
Sell14:00
Purchase and redemption terms
Minimum first purchaseNot specified
Minimum subsequent purchaseNot specified
Minimum redemptionNot specified
Minimum units per redemptionNot specified
Minimum balanceNot specified
Minimum unit balanceNot specified
Redemption settlement periodT+4Business days after the order date
กองทุนมีนโยบายเน้นลงทุนในหน่วยลงทุนของกองทุนรวมต่างประเทศ (หรือ “กองทุนหลัก (Master fund)”) เฉลี่ยในรอบปีบัญชีไม่น้อยกว่าร้อยละ 80 ของมูลค่าทรัพย์สินสุทธิ Its largest holdings are Johnson & Johnson 9.74% · Eli Lilly & Co 9.44% · Merck & Co., Inc 6.43% (fact sheet 30 Oct 2026)
How risky is it?+−
Risk level 7 of 8 (High risk). Since 20 Nov 2023, its NAV has fallen as much as −24.18% from its peak.
What are the fees?+−
Actual total expense ratio (TER) 2.16% a year, against a ceiling of 5.00%. Management fee 1.61%. Front-end fee 0.00%. Back-end fee 0.00%. (Fact sheet 30 Sep 2026)
Does it pay dividends?+−
No. Gains or losses accumulate in the NAV, and investors receive their return when they redeem units
What is the minimum purchase, and when do I get my money after selling?+−
Minimum first purchase not set, subsequent purchases not set. Buy orders accepted until 14:00, sell orders until 14:00, and redemption proceeds are paid T+4
Does it hedge currency risk?+−
Hedged at the manager's discretion. As of 30 Oct 2026, 86.61% of the value of its foreign investments was hedged
How is LHHEALTH-ASSF different from LHHEALTH-A / LHHEALTH-D / LHHEALTH-DSSF / LHHEALTH-E?+−
They are share classes of the same fund and invest in the same assets. They differ only in each class's terms, such as dividend policy, fees or who can buy · LHHEALTH-ASSF: no dividends, TER 2.16% · LHHEALTH-A: no dividends, TER 2.16% · LHHEALTH-D: pays dividends, TER 2.16% · LHHEALTH-DSSF: pays dividends, TER 2.16% · LHHEALTH-E: no dividends, TER 2.16%
Warning Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Based on the master fund's share of this fund's value (96.78% as of 30 Sep 2026) × each stock's weight in the master fund · fact sheet from AllianceBernstein · Illustrations are for explanation only, not individual stock recommendations
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Only SSF share classes are counted, and only funds with a full track record for the period are included · Calculated from NAV as of 16 Nov 2026